Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Geron (GERN) EBT (2016 - 2025)

Geron (GERN) has disclosed EBT for 16 consecutive years, with -$28.8 million as the latest value for Q4 2025.

  • Quarterly EBT fell 22.02% to -$28.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$83.1 million through Dec 2025, up 51.85% year-over-year, with the annual reading at -$83.1 million for FY2025, 51.85% up from the prior year.
  • EBT hit -$28.8 million in Q4 2025 for Geron, down from -$18.3 million in the prior quarter.
  • In the past five years, EBT ranged from a high of -$16.3 million in Q2 2025 to a low of -$67.3 million in Q2 2024.
  • Historically, EBT has averaged -$35.0 million across 5 years, with a median of -$29.8 million in 2021.
  • Biggest five-year swings in EBT: tumbled 81.48% in 2021 and later skyrocketed 75.77% in 2025.
  • Year by year, EBT stood at -$32.0 million in 2021, then tumbled by 33.46% to -$42.7 million in 2022, then fell by 21.75% to -$52.0 million in 2023, then soared by 54.63% to -$23.6 million in 2024, then dropped by 22.02% to -$28.8 million in 2025.
  • Business Quant data shows EBT for GERN at -$28.8 million in Q4 2025, -$18.3 million in Q3 2025, and -$16.3 million in Q2 2025.